Press Releases

STOCKHOLM, SWEDEN / ACCESSWIRE / May 31, 2024 / Hilbert Group (STO:HILB-B)(FRA:999) May 31, 2024

The first quarter 2024

(compared to first quarter 2023)

• Revenues amounted to kSEK 11,930.7 (kSEK 5,979.2)
• Operating loss (EBIT) totaled kSEK -7,997.8 (kSEK -8,038.8)
• Result for the period was kSEK -3,520.3 (kSEK -8,831.7)
• Net cash flow from operating activities amounted to kSEK 8,876.8 (kSEK 4,945.2)
• Earnings per share before and after dilution amounted to SEK -0.05 (SEK -0.16)

A... (continue reading...)

Company's good4uSM Crew will be accepting monetary donations at three locations through June 30

LAKEWOOD, Colo., May 31, 2024 /PRNewswire/ -- Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S. is collecting donations for the American Red Cross to benefit communities affected by the recent severe tornado damage at three select stores in Iowa and Texas.

... (continue reading...)

TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that the European Patent Office granted the Company’s patent application titled “Compositions and Methods of Potentiating Antimicrobials”. This is in addition to the patent... (continue reading...)

• Lac des Iles mine production ramping up to meet customer demand and increase operating income
• Record first quarter sales volumes and revenues
• Strict cost control measures being implemented to preserve working capital

Ottawa, Ontario--(Newsfile Corp. - May 31, 2024) - Northern Graphite Corporation (TSXV: NGC) (OTCQB: NGPHF) (FSE: 0NG) (XSTU: 0NG) (the "Company" or "Northern") is pleased to provide an operating summary and financial highlights for the three month period... (continue reading...)

TEL AVIV, Israel, May 31, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that the European Patent Office granted the Company’s patent application titled “Compositions and Methods of Potentiating Antimicrobials”. This is in addition to the patent... (continue reading...)